Tefferi A - Search Results

1

Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients.

Carobbio A, Thiele J, Passamonti F, Rumi E, Ruggeri M, Rodeghiero F, Randi ML, Bertozzi I, Vannucchi AM, Antonioli E, Gisslinger H, Buxhofer-Ausch V, Finazzi G, Gangat N, Tefferi A, Barbui T. Carobbio A, et al. Among authors: tefferi a. Blood. 2011 Jun 2;117(22):5857-9. doi: 10.1182/blood-2011-02-339002. Epub 2011 Apr 13. Blood. 2011. PMID: 21490340 Free article.

2

New drugs in essential thrombocythemia and polycythemia vera.

Tefferi A, Elliott MA, Solberg LA Jr, Silverstein MN. Tefferi A, et al. Blood Rev. 1997 Mar;11(1):1-7. doi: 10.1016/s0268-960x(97)90001-1. Blood Rev. 1997. PMID: 9218101 Review.

3

Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG.

Michiels JJ, Barbui T, Finazzi G, Fuchtman SM, Kutti J, Rain JD, Silver RT, Tefferi A, Thiele J. Michiels JJ, et al. Among authors: tefferi a. Leuk Lymphoma. 2000 Jan;36(3-4):239-53. doi: 10.3109/10428190009148845. Leuk Lymphoma. 2000. PMID: 10674896 Review.

4

Long-term use of anagrelide in young patients with essential thrombocythemia.

Storen EC, Tefferi A. Storen EC, et al. Among authors: tefferi a. Blood. 2001 Feb 15;97(4):863-6. doi: 10.1182/blood.v97.4.863. Blood. 2001. PMID: 11159509 Free article.

5

Current opinion in essential thrombocythemia: pathogenesis, diagnosis, and management.

Tefferi A, Murphy S. Tefferi A, et al. Blood Rev. 2001 Sep;15(3):121-31. doi: 10.1054/blre.2001.0158. Blood Rev. 2001. PMID: 11735160 Review.

6

Hemostatic gene polymorphisms and the prevalence of thrombotic complications in polycythemia vera and essential thrombocythemia.

Afshar-Kharghan V, López JA, Gray LA, Padilla A, Borthakur G, Roberts SC, Pruthi RK, Tefferi A. Afshar-Kharghan V, et al. Among authors: tefferi a. Blood Coagul Fibrinolysis. 2004 Jan;15(1):21-4. doi: 10.1097/00001721-200401000-00004. Blood Coagul Fibrinolysis. 2004. PMID: 15166939

7

bcr/abl-negative, classic myeloproliferative disorders: diagnosis and treatment.

Tefferi A, Barbui T. Tefferi A, et al. Mayo Clin Proc. 2005 Sep;80(9):1220-32. doi: 10.4065/80.9.1220. Mayo Clin Proc. 2005. PMID: 16178503 Review.

8

Estrogen-based hormone therapy and thrombosis risk in women with essential thrombocythemia.

Gangat N, Wolanskyj AP, Schwager SM, Mesa RA, Tefferi A. Gangat N, et al. Among authors: tefferi a. Cancer. 2006 Jun 1;106(11):2406-11. doi: 10.1002/cncr.21891. Cancer. 2006. PMID: 16628652 Free article.

9

International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT).

Tefferi A, Barosi G, Mesa RA, Cervantes F, Deeg HJ, Reilly JT, Verstovsek S, Dupriez B, Silver RT, Odenike O, Cortes J, Wadleigh M, Solberg LA Jr, Camoriano JK, Gisslinger H, Noel P, Thiele J, Vardiman JW, Hoffman R, Cross NC, Gilliland DG, Kantarjian H; IWG for Myelofibrosis Research and Treatment (IWG-MRT). Tefferi A, et al. Blood. 2006 Sep 1;108(5):1497-503. doi: 10.1182/blood-2006-03-009746. Epub 2006 May 4. Blood. 2006. PMID: 16675707 Free article. Review.

10

Abdominal vein thrombosis in essential thrombocythemia: prevalence, clinical correlates, and prognostic implications.

Gangat N, Wolanskyj AP, Tefferi A. Gangat N, et al. Among authors: tefferi a. Eur J Haematol. 2006 Oct;77(4):327-33. doi: 10.1111/j.1600-0609.2006.00715.x. Epub 2006 Jul 19. Eur J Haematol. 2006. PMID: 16856928

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,188 results

Search Page

Filters